Bard PowerPort patients who suffered fractures, migration, or infections may be entitled to significant compensation. Free case review, no obligation.
Confidential. No obligation. Takes about 2 minutes.
If most of the following apply to you or a loved one, you may have a strong case. Our team will review your eligibility for free.
Estimated settlement value range for severe injury cases. Individual settlements depend on injury severity, medical expenses, and other factors.
Estimates based on comparable medical device MDL settlements. Past results do not guarantee future outcomes.Established in 2000, we've connected tens of thousands of injury victims with leading mass tort attorneys nationwide.
Cases are handled on contingency by our network attorneys. You pay nothing up front and nothing unless your case is successful.
From the first defective drug litigation in our 30-year history to today's mass torts, we've helped countless victims connect with experienced attorneys.
Complete our 2-minute confidential intake form. Tell us about your Port-A-Cath experience.
Our case specialists review your information and assess your eligibility — at no cost to you.
If you qualify, we connect you with a network attorney experienced in Bard PowerPort litigation.
The Judicial Panel on Multidistrict Litigation consolidated federal Bard PowerPort cases into MDL 3081 (D. Ariz.) under Judge David Campbell to streamline pretrial proceedings.
The FDA has issued multiple safety communications and recalls related to Bard implantable port catheters following reports of catheter fractures and patient injuries.
The court has ordered a bellwether trial program to test representative cases. Outcomes are expected to inform global settlement negotiations across the entire MDL.
A Port-A-Cath is a small, implanted device that allows medical providers to deliver medication, fluids, or nutrition directly into a patient's bloodstream — often used for chemotherapy, antibiotics, or long-term IV therapy. The Bard PowerPort, manufactured by Bard Access Systems (a subsidiary of Becton Dickinson), is one of the most widely implanted models and has been linked to fractures, migrations, and serious infections.
Qualifying injuries generally include catheter fracture (the catheter breaking inside the body), catheter migration (movement to an unintended location), severe infection requiring hospitalization, blood clots, perforation of vessels or organs, and complications requiring explant (removal) surgery.
Compensation depends on the severity of your injuries, medical expenses, lost wages, and pain and suffering. Bellwether cases in the Bard PowerPort MDL are anticipated to set settlement value ranges; individual cases can vary widely. There is no guaranteed amount, and any prior result does not guarantee a similar outcome.
Mass tort cases typically take 12 to 36 months, though timelines vary based on bellwether trial outcomes, settlement negotiations, and the specifics of your individual claim.
No. Network attorneys handle these cases on a contingency basis — you pay nothing unless your claim is successful. The case review is always free with no obligation.
In August 2023, the Judicial Panel on Multidistrict Litigation (JPML) consolidated federal Bard PowerPort cases into MDL 3081 in the U.S. District Court for the District of Arizona. An MDL streamlines pretrial proceedings (discovery, motions, expert challenges) for thousands of similar claims, but each plaintiff's case remains individual.
Don't worry — submit your information anyway. Our team can help obtain your medical records and identify the manufacturer of your implanted device at no cost to you. Many patients aren't told the manufacturer name at the time of implant.